Here’s the latest company planning for gene-edited babies The news: A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

RESEARCHERS at Massachusetts Institute of Technology (MIT) have developed a method to purify gene therapies 10 times more quickly than conventional processes, paving the way to lower prices for the ...

Chemists at the National University of Singapore (NUS) have found a new use for deoxyribonucleic acid (DNA), not just as ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will showcase 46 abstracts, including 12 oral presentations, from its industry-leading hematology portfolio ...